Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001393905-21-000016
Filing Date
2021-01-25
Accepted
2021-01-25 14:07:39
Documents
1
Period of Report
2020-12-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2045
  Complete submission text file 0001393905-21-000016.txt   3607
Mailing Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240
Business Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240 214-236-1363
Rapid Therapeutic Science Laboratories, Inc. (Issuer) CIK: 0001575659 (see all company filings)

EIN.: 462111820 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7108 DUFFIELD DR. DALLAS TX 75248
Business Address
Berrier Sean Paul (Reporting) CIK: 0001837090 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55018 | Film No.: 21549251